Bibliographie - 2803 - Stabilis 4.0

Siste oppdatering :
19/11/2024

Referanser 2803

Type :

Journal

Forskerteamet :

Marlborough - Sepracor Inc

Forfattere :

Bonasia PJ, McVicar WK, Williams B, Ong S.

Tittel :

Chemical and physical compatibility of levalbuterol inhalation solution concentrate mixed with budesonide, ipratropium bromide, cromolyn sodium or acetylcysteine sodium.

Nummer :

Respiratory Care ; 683, 12: 1716-1722. 2008

Nivå of Evidence :

fysisk stabilitet :

kjemisk stabilitet :

andre metoder :

Kommentarer :

Lister

Budesonide

Cromoglycate sodium

Ipratropium bromide

Levalbuterol

N-acetylcysteine

Ingen

21-25°C

N-acetylcysteine	®=? Acetylcysteine sodium Bristol Myers Squibb® 182 mg/l
Levalbuterol	®=? Levalbuterol Sepracor® 0.22 mg/

0.5

Ingen

21-25°C

Levalbuterol	®=? Levalbuterol Sepracor® 0.41 mg/ml
Ipratropium bromide	®=? Ipratropium bromide Dey® 0.16 mg/ml

0.5

Ingen

21-25°C

Budesonide	®=? Budesonide Astra Zeneca 0.2 mg/mL
Levalbuterol	®=? Levalbuterol Sepracor® 0.5 mg/mL

0.5

Ingen

21-25°C

Levalbuterol	®=? Levalbuterol Sepracor® 0.5 mg/ml
Cromoglycate sodium	®=? Cromolyn sodium Alpharma® 8 mg/ml

0.5

Mentions Légales